Question 17

(Multiple Choice)

Recombinant human monoclonal antibody (rhuMAb)


A)appears promising as a treatment for asthma.
B)decreases the levels of IgG.
C)uses an engineered form of an IgG molecule.
D)promotes crosslinking between IgE molecules on the mast cells.
E)appears promising as a treatment for asthma AND uses an engineered form of an IgG molecule.

Answer